. Each 3ml vial is formulated with 5mg of highly purified (>99%) lyophilized CJC-1295 No DAC, and 5mg of highly purified (>99%) lyophilized Ipamorelin produced in sterile environments that meet research-grade standards. Prime Peptides validates every batch through third-party laboratory testing to ensure exact molecular composition, stable peptide structure, and consistent results suitable for a wide range of experimental designs.
SALE
FEATURED PRODUCTS
CJC/IPA Blend 10mg (CJC-1295 No DAC + Ipamorelin)
Third-Party Tested
CJC-1295 No DAC + Ipamorelin Blend
The Gold-Standard Research Stack for Pulsatile GH Release
The CJC-1295 (No DAC) + Ipamorelin blend is one of the most widely studied growth hormone–releasing combinations in peptide research. By pairing a GHRH analog (CJC No DAC) with a GHRP (Ipamorelin), researchers explore amplified pulsatile GH release, enhanced pituitary signaling, and improved GH/IGF-1 axis activity in experimental models. This synergistic blend helps mimic natural GH patterns more closely than either peptide alone.
✓
In stock – Ships same day
SSL Secured
Secure Checkout
Guaranteed Delivery
Third-Party Tested
LAB RECORD // PRODUCT SPECIFICATION
Research Profile
PRODUCT STATUS
See product status
See product status
A concise product record covering the stated research format and supporting batch documentation.
- Compound
- —
- Stated amount
- —
- Format
- —
Access the current Certificate of Analysis index and batch-specific verification records.
Open COA index ↗CJC-1295 No DAC + Ipamorelin Blend
The Gold-Standard Research Stack for Pulsatile GH Release
The CJC-1295 (No DAC) + Ipamorelin blend is one of the most widely studied growth hormone–releasing combinations in peptide research. By pairing a GHRH analog (CJC No DAC) with a GHRP (Ipamorelin), researchers explore amplified pulsatile GH release, enhanced pituitary signaling, and improved GH/IGF-1 axis activity in experimental models. This synergistic blend helps mimic natural GH patterns more closely than either peptide alone.
Research Areas of Interest
All information below is intended strictly for scientific, laboratory, and in-vitro research only.
Dual-Pathway GH Stimulation
- CJC-1295 No DAC activates GHRH receptors
- Ipamorelin activates ghrelin (GHS-R1a) receptors
Together, they stimulate GH release through two independent pathways, producing a stronger peak.
Enhanced GH Pulse Amplitude
Research shows that combining GHRH + GHRP:
- Increases GH pulse size and strength
- Improves GH secretion reliability
- Supports a more physiological GH pattern
IGF-1 Pathway Support
Greater GH release leads to elevated IGF-1 production, which is studied for roles in:
- Muscle-cell activity
- Tissue repair
- Metabolic regulation
- Cellular growth pathways
CJC-1295 No DAC + Ipamorelin Blend
The Gold-Standard Research Stack for Pulsatile GH Release
The CJC-1295 (No DAC) + Ipamorelin blend is one of the most widely studied growth hormone–releasing combinations in peptide research. By pairing a GHRH analog (CJC No DAC) with a GHRP (Ipamorelin), researchers explore amplified pulsatile GH release, enhanced pituitary signaling, and improved GH/IGF-1 axis activity in experimental models. This synergistic blend helps mimic natural GH patterns more closely than either peptide alone.
Lab Report
Research Use Disclaimer
Research Use Only: All products offered are intended strictly for laboratory research purposes. Products are not for human consumption and are not intended for diagnostic, therapeutic, or medical use. By purchasing from our website, customers confirm they are qualified researchers or laboratories and understand the intended research-use designation.
Related Compounds
GH 120iu: 12iu x 10 Vials
Original price was: $330.00.$250.00Current price is: $250.00.
DSIP 5mg: Delta Sleep-Inducing Peptide
$45.00
Ipamorelin 5mg Nasal Spray: 100mcg per Spray
$75.00
Hexarelin 5mg Nasal Spray: 100mcg per spray
$105.00